It presents exogenous antigens to CD4+ regulatory T cells, helper T cells (Th) and inhibitory T cells (Ts) and participates in the immune response process.[19] HLA-DRB1, as an immune effector molecule, plays an important role in the occurrence and development of breast cancer. This evidence concerns the gene HLA-DRB1 and breast carcinoma.